2015 - TID 2015 Conference


Bad Bugs - Managing Challenging Infections Post-Transplant

2.4 - Tuberculosis in Transplant Recipients (with Spanish Audio Translation)

Presenter: Michele I., Morris, Miami, United States
Authors: Michele I. Morris


Overview

Transplant recipients are at significantly higher risk of tuberculosis when compared to the general population. Tuberculosis post-transplant may have an atypical presentation and is often disseminated at the time of diagnosis. Delays in diagnosis may account for some of the increased morbidity and mortality observed. Identifying and treating latent tuberculosis in transplant candidates may decrease the risk of post-transplant TB. An understanding of the potential drug toxicities and drug-drug interactions associated with anti-mycobacterial therapy is essential to manage latent or active TB in the transplant patient. Careful patient monitoring as well as close collaboration between the transplant team and the infectious disease specialist or TB professional is required for successful graft and patient outcomes. This talk will review some of the most common challenges faced in treating latent and active tuberculosis in transplant patients.

Objectives

  1. Identify the risk factors for tuberculosis in transplant recipients
  2. Understand the treatment options for latent tuberculosis in transplant candidates
  3. Understand the most common management challenges faced in treating tuberculosis post-transplant

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi